Oil prices surged, global stocks sank and gold rose Monday as concerns about a broadening war with Iran began to ripple through financial markets. Investors are bracing for volatility in global energy ...
Qure stock plunged 45% after FDA rejected AMT-130 approval pathway, requiring new randomized trial for Huntington's disease gene therapy program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results